Jeremiah Karrs, DO
@KarrsJeremiah
Heme/molecular pathologist at #DHpath, #AP/CP #MGP trained @VCUHealth #Hemepath @NIH T/RT ≠ medical advice; views are my own; @WVSOM alum, #WestVirginia native
ID:1245801375298093059
02-04-2020 19:52:55
7,2K Tweets
2,4K Followers
1,9K Following
Panel Comparative Analysis Tool: An Open-Source Comparative Analysis Tool for #NextGenSeq Panel Target Regions. Authors from MedUni Wien and Pathologie_MedUniWien
#OpenAccess text: jmdjournal.org/article/S1525-…
AEL transformed from post-ET myelofibrosis with a sinusoidal pattern, JAK2 mutation, and biallelic TP53 inactivation
ow.ly/Nj9U50RIL7r #bloodwork #myeloidneoplasia
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System
ow.ly/7yPV50RJrti #clinicaltrialsandobservations #genetherapy
Send in your #moldx #molpath advancements to J Mol Diagnostics for consideration today! JMD is the flagship journal of Association for Molecular Pathology and submission is free!
editorialmanager.com/jmdi/default2.…
Excited to share joint effort shorturl.at/gjCOR with Eytan Ruppin, MD, PhD group in Nature Medicine, where we use deep learning to predict DNA methylation patterns from H&E images. Working to develop further to assist in diagnostics.
#neuropath #pathology #PathTwitter
Please join us for LUC by Dr. Medeiros @4PM CT tomorrow
📢Meeting: bit.ly/4bAGjHh
ID: 880 5496 5925 code: 893296
Slides: bit.ly4bCNTRG
#hemepath #pathedu #pathtwitter
SHUYU E MD, PhD PaulYoungMD @kirillLyapichev Siba El Hussein, MD
Excited to be part of the international i4MDS consortium studying the immune system in #MDSsm and led by Shahram Kordasti; position paper out today in HemaSphere Journal (IF = 9.1) gives a great overview and outlines recommendations for immune monitoring. onlinelibrary.wiley.com/doi/full/10.10… #BMFsm #CCUS #CHIP
Thrilled to see our i4MDS position paper out in HemaSphere Journal (IF = 9.1) today. This work was led by Kordasti_lab and provides a framework for immune monitoring in patients with #MDSsm and related conditions. The aim of i4MDS is to enhance MDS stratification, identify predictive markers of
Tune in to hear why you might want to consider meeting your #pathologist . Thank you to MA Breast Cancer Coalition for the opportunity to highlight the special role of pathology in #breastcancer Video here youtube.com/watch?v=efPy3u…